Close Menu
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
What's Hot

A new molecular model of bilayer graphene with higher semiconducting properties

May 31, 2025

5 Nanomaterial Innovations That Didn’t Deliver (Yet)

May 30, 2025

Scientists identify new 2D copper boride material with unique atomic structure

May 30, 2025
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
Home»Research»Advancing the Frontiers of Cancer Treatment: Tel Aviv University’s Groundbreaking RNA Therapy for Multiple Myeloma
Research

Advancing the Frontiers of Cancer Treatment: Tel Aviv University’s Groundbreaking RNA Therapy for Multiple Myeloma

August 21, 2023No Comments4 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
Advancing the Frontiers of Cancer Treatment: Tel Aviv University’s Groundbreaking RNA Therapy for Multiple Myeloma
Share
Facebook Twitter LinkedIn Pinterest Telegram Email

In the face of the relentless global scourge of multiple myeloma, a blood cancer found typically among the elderly, scientists across the globe are in a frantic search for effective treatments.

This cancer forms tumours within the bone marrow, making it particularly challenging to combat. Patients suffer from severe bone pain, anaemia, kidney failure, and a significantly weakened immune system.

RNA Therapy: A New Frontier in Cancer Treatment

A team of researchers from Tel Aviv University and Rabin Medical Center have offered a glimmer of hope with their groundbreaking RNA-based treatment. Using lipid-based nanoparticles to deliver RNA molecules designed to silence the gene CKAP5, they have achieved staggering results, successfully destroying 90% of multiple myeloma cells under laboratory conditions and 60% in human tissue samples.

This new therapeutic approach is especially promising as it can be tailored quickly to individual patients’ needs. Different genes can be silenced each time by merely adjusting the RNA molecule, creating a custom solution for each patient based on the disease’s progression. Moreover, this therapy is uniquely capable of reaching cancer cells within the bone marrow, a significant advantage over other forms of treatment.

Dana Tarab-Ravski, PhD student involved in the research said, “RNA-based therapy has a great advantage in this case because it can be developed very quickly. By simply changing the RNA molecule, a different gene can be silenced each time, thereby tailoring the treatment to the progression of the disease and to the individual patient. The challenge in these treatments is to reach the right cells.”

This RNA-based therapy can be personalised and can even reach tricky areas like bone marrow, and it’s a big reason why the market for it is expected to grow so much.

See also  How Hyundai's Nanotechnology Advances Are Shaping the Future of the Automotive Industry

According to Research and Markets, the global market size for the RNA-Based Therapeutic Market is anticipated to attain over $11 billion by 2027, exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 15.1% during the forecast period.

Overcoming Obstacles: The Path Ahead for RNA Therapy

While promising, the innovative RNA-based therapy for multiple myeloma confronts a series of challenges before it becomes accessible as a widely used treatment.

Firstly, regulatory hurdles pose a substantial barrier. Treatments must pass rigorous testing and obtain approval from health authorities, such as the FDA or EMA. This comprehensive examination, meant to ensure safety and efficacy, includes multiple stages of trials and can significantly prolong the treatment’s journey to the market.

Secondly, the financial costs associated with drug development are steep. The process involves extensive R&D expenditures, from lab equipment and expert personnel to clinical trials and regulatory procedures. Securing ample funding can often prove to be a daunting task.

Lastly, potential resistance from established pharmaceutical entities may present a challenge. Introducing a new, unproven treatment could disrupt the industry’s status quo, potentially causing pushback from current market leaders.

Despite these challenges, the potential of this therapy has garnered attention in the investment world. Alnylam, with total funding of $17 million, a pioneering company in the healthcare sector, is making significant strides in developing RNA interference-based therapeutics. Their efforts span across a wide array of disorders, showcasing their comprehensive approach to disease management.

A spokesperson for the company said, “Medicines based on RNAi work by “silencing” or disabling the production of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms.”

See also  Navigating the Complex Landscape of Nanotech Funding

Conclusion

The development and refinement of RNA-based therapies hold great promise in revolutionising multiple myeloma treatment. The increasing investment in this field enhances the likelihood of overcoming existing challenges and making these innovative therapies more accessible to patients. Continued advancements indicate that the world may be approaching a new era in cancer treatment, presenting significant opportunities for improved patient outcomes and medical advancements.

Source link

Advancing Aviv cancer Frontiers Groundbreaking Multiple Myeloma RNA Tel Therapy Treatment Universitys
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Drug-loaded nanoparticles can enhance precision and safety of ultrasound tumor treatment

May 27, 2025

Biosensor uses pH-responsive DNA nanoswitches for highly sensitive bladder cancer detection in urine

May 24, 2025

Carbon nanotube-based strain sensor can detects deformations in multiple directions

May 4, 2025

Nanoparticle treatment combined with radiation therapy significantly improves glioblastoma survival in mice

May 3, 2025

In What Ways Can Nanosensors Be Used to Detect Cancer?

April 22, 2025

Ultra-thin, flexible silicone nanosensor could have huge impact on brain injury treatment

April 22, 2025

Comments are closed.

Top Articles
News

Chemists create world’s thinnest spaghetti

News

New sensors measure uric acid levels better than other noninvasive methods

News

Ultrathin conductor surpasses copper for more energy-efficient nanoelectronics

Editors Picks

A new molecular model of bilayer graphene with higher semiconducting properties

May 31, 2025

5 Nanomaterial Innovations That Didn’t Deliver (Yet)

May 30, 2025

Scientists identify new 2D copper boride material with unique atomic structure

May 30, 2025

New contact lenses allow wearers to see in the near-infrared

May 30, 2025
About Us
About Us

Your go-to source for the latest nanotechnology breakthroughs. Explore innovations, applications, and implications shaping the future at the molecular level. Stay informed, embrace the nano-revolution.

We're accepting new partnerships right now.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Tissue-integrated sensitive glucose nanosenor uses inactive glucose oxidase enzyme for continuous monitoring

January 9, 2024

World’s First Miniature Particle Accelerator Unveiled

October 21, 2023

TU Dresden researchers develop highly innovative solutions for the detection of viral pathogens

September 16, 2023

Subscribe to Updates

Get the latest creative Nano Tech news from Elnano.com

© 2025 Elnano.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.

Cleantalk Pixel